$Eidos Therapeutics(EIDX)$ 非常不错的数据！ AG10 Resulted in Average TTR Stabilization Greater than 90% in All Actively Treated Subjects at Day 28. AG10 Significantly Raised Serum TTR Concentrations (p<0.0001) by 50% and 36% in Subjects Administered 800 mg Twice Daily and 400 mg Twice Daily, Respectively, at Day 28.Normalized Serum TTR Levels Observed in All Actively Treated Subjects at Day 28.